FI20085007A0 - Koostumus maksan metabolismin parantamiseksi ja diagnostinen menetelmä - Google Patents

Koostumus maksan metabolismin parantamiseksi ja diagnostinen menetelmä

Info

Publication number
FI20085007A0
FI20085007A0 FI20085007A FI20085007A FI20085007A0 FI 20085007 A0 FI20085007 A0 FI 20085007A0 FI 20085007 A FI20085007 A FI 20085007A FI 20085007 A FI20085007 A FI 20085007A FI 20085007 A0 FI20085007 A0 FI 20085007A0
Authority
FI
Finland
Prior art keywords
composition
diagnostic method
improving liver
liver metabolism
metabolism
Prior art date
Application number
FI20085007A
Other languages
English (en)
Swedish (sv)
Other versions
FI20085007A (fi
FI122252B (fi
Inventor
Taru Pilvi
Eero Mervaala
Riitta Korpela
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Oy filed Critical Valio Oy
Priority to FI20085007A priority Critical patent/FI122252B/fi
Publication of FI20085007A0 publication Critical patent/FI20085007A0/fi
Priority to KR1020107017406A priority patent/KR20100108585A/ko
Priority to JP2010541075A priority patent/JP2011509249A/ja
Priority to EP08869918A priority patent/EP2247295A4/en
Priority to CN2008801237695A priority patent/CN101918009A/zh
Priority to PCT/FI2008/050796 priority patent/WO2009087263A1/en
Priority to US12/811,266 priority patent/US20100285152A1/en
Publication of FI20085007A publication Critical patent/FI20085007A/fi
Application granted granted Critical
Publication of FI122252B publication Critical patent/FI122252B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/10—Whey; Whey preparations containing inorganic additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
FI20085007A 2008-01-04 2008-01-04 Koostumus maksa-aineenvaihdunnan parantamiseksi ja diagnostinen menetelmä FI122252B (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20085007A FI122252B (fi) 2008-01-04 2008-01-04 Koostumus maksa-aineenvaihdunnan parantamiseksi ja diagnostinen menetelmä
KR1020107017406A KR20100108585A (ko) 2008-01-04 2008-12-31 간의 대사작용을 개선하기 위한 조성물 및 진단방법
JP2010541075A JP2011509249A (ja) 2008-01-04 2008-12-31 肝臓代謝を改善するための組成物および診断方法
EP08869918A EP2247295A4 (en) 2008-01-04 2008-12-31 COMPOSITION FOR IMPROVING HEPATIC METABOLISM AND DIAGNOSTIC METHOD
CN2008801237695A CN101918009A (zh) 2008-01-04 2008-12-31 用于改善肝脏代谢的组合物和诊断方法
PCT/FI2008/050796 WO2009087263A1 (en) 2008-01-04 2008-12-31 Composition for improving liver metabolism and diagnostic method
US12/811,266 US20100285152A1 (en) 2008-01-04 2008-12-31 Composition for improving liver metabolism and diagnostic method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20085007 2008-01-04
FI20085007A FI122252B (fi) 2008-01-04 2008-01-04 Koostumus maksa-aineenvaihdunnan parantamiseksi ja diagnostinen menetelmä

Publications (3)

Publication Number Publication Date
FI20085007A0 true FI20085007A0 (fi) 2008-01-04
FI20085007A FI20085007A (fi) 2009-07-05
FI122252B FI122252B (fi) 2011-10-31

Family

ID=39004307

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20085007A FI122252B (fi) 2008-01-04 2008-01-04 Koostumus maksa-aineenvaihdunnan parantamiseksi ja diagnostinen menetelmä

Country Status (7)

Country Link
US (1) US20100285152A1 (fi)
EP (1) EP2247295A4 (fi)
JP (1) JP2011509249A (fi)
KR (1) KR20100108585A (fi)
CN (1) CN101918009A (fi)
FI (1) FI122252B (fi)
WO (1) WO2009087263A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201002332A (en) * 2008-07-07 2010-01-16 Univ Nat Chunghsing Composition for preventing and controlling fatty liver disease
JP5980519B2 (ja) * 2012-02-15 2016-08-31 株式会社ディーエイチシー Ａｍｐｋ活性化剤
WO2014154494A1 (en) * 2013-03-28 2014-10-02 Nestec S.A. Alpha-keto-isovalerate as a biomarker of prebiotic efficacy for weight gain prevention
JP6872841B2 (ja) * 2014-04-28 2021-05-19 アサマ化成株式会社 脂肪低減組成物
CN104297442B (zh) * 2014-11-03 2016-08-17 天津中医药大学 内源性小分子物质在快速检测早期心脏毒性方面的应用
CN112147266B (zh) * 2020-09-25 2022-11-08 中国水产科学研究院淡水渔业研究中心 一种基于lc-ms技术确定患脂肪肝病罗非鱼肝脏异常代谢特征的方法
CN114166986B (zh) * 2021-12-16 2024-09-24 深圳市龙岗中心医院(深圳市龙岗中心医院集团、深圳市第九人民医院、深圳市龙岗中心医院针灸研究所) 胎粪代谢标志物及其筛选方法、应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08259461A (ja) * 1995-03-24 1996-10-08 Snow Brand Milk Prod Co Ltd 脂質代謝改善剤
CN1045246C (zh) * 1995-08-07 1999-09-29 吴宏伟 减肥口香糖
JP3599347B2 (ja) * 1995-09-06 2004-12-08 協和醗酵工業株式会社 脂質代謝改善剤
JP4034516B2 (ja) * 2001-01-16 2008-01-16 雪印乳業株式会社 脂質代謝改善剤
JP4028177B2 (ja) * 2001-01-16 2007-12-26 雪印乳業株式会社 血圧降下剤
US20030040475A1 (en) * 2001-01-16 2003-02-27 Yasuhiro Toba Agents for improving lipid metabolism and reducing high blood pressure
JP2002226394A (ja) * 2001-02-01 2002-08-14 Meiji Milk Prod Co Ltd 脂質代謝改善組成物
US20040156882A1 (en) * 2002-10-23 2004-08-12 Davenport David F. Method and composition for feeding mammals
TWI317636B (en) * 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
US9592201B2 (en) * 2003-11-21 2017-03-14 Commonwealth Scientific And Industrial Research Organisation Gi track delivery systems
WO2005099483A1 (en) * 2004-04-16 2005-10-27 Indevex Ab Ingestible composition
EA200802072A1 (ru) * 2006-04-13 2009-04-28 Камедика Лимитед Ликопин для лечения нарушения обмена веществ
CA2662987A1 (en) * 2006-08-08 2008-02-21 Tethys Bioscience, Inc. Markers of non-alcoholic fatty liver disease (nafld) and non-alcoholic steatohepatitis (nash) and methods of use thereof

Also Published As

Publication number Publication date
WO2009087263A1 (en) 2009-07-16
EP2247295A1 (en) 2010-11-10
KR20100108585A (ko) 2010-10-07
JP2011509249A (ja) 2011-03-24
US20100285152A1 (en) 2010-11-11
CN101918009A (zh) 2010-12-15
FI20085007A (fi) 2009-07-05
FI122252B (fi) 2011-10-31
EP2247295A4 (en) 2011-09-07

Similar Documents

Publication Publication Date Title
BRPI0920284A2 (pt) composição e método
BRPI0918170A2 (pt) método, e, composição endurecível
BRPI0914427C8 (pt) composição dental endurecível
DK2273984T3 (da) Lipidsammensætning
BRPI0919575A2 (pt) método, e, composição
FI20075978A0 (fi) Järjestely ja menetelmä
BRPI0906749A2 (pt) Composição
BRPI0913808A2 (pt) composição
IT1392101B1 (it) Composizione comprendente isoflavoni
BRPI0905715A2 (pt) Composição farmacêutica e kit de componentes
BRPI0823277A2 (pt) Composição, e , método
BRPI0917231A2 (pt) composição
FI20070935A0 (fi) Koostumus ja menetelmä puun käsittelemiseksi
ZA201102035B (en) Methods and formulations for treating chronic liver disease
EP2235201A4 (en) METHODS AND COMPOSITIONS FOR THE ASSAY OF HOMOCYSTEINE
FI20085007A (fi) Koostumus maksan metabolismin parantamiseksi ja diagnostinen menetelmä
IL210682A0 (en) Glass hardening methods and compositions
BRPI0909892A2 (pt) composição vedante
BRPI0823238A2 (pt) Composição, e, método
FI20085158A0 (fi) Laite ja menetelmä
BRPI0916632A2 (pt) método para composição de banner dinâmico
DK2027864T3 (da) Sammensætning til forbedring af lipimetabolismen
FI20075078A (fi) Menetelmä ja järjestely vaihtosuuntaajan yhteydessä
BRPI0918279A2 (pt) método de diagnóstico e kit de diagnóstico para dermatomiosite
BRPI0912074A2 (pt) composto e composição farmacêutica

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 122252

Country of ref document: FI

MM Patent lapsed